Chaetoglobosin E inhibits tumor growth and promotes the anti-tumor efficacy of cytotoxic drugs in esophageal squamous cell carcinoma by targeting PLK1

BACKGROUND: Currently, there is no satisfactory treatment available for esophageal squamous cell carcinoma (ESCC), and thus, there is a pressing need to develop effective drugs. Chaetoglobosin E, a cytochalasan alkaloid derived from metabolites of Chaetomium madrasense 375, is a chaetoglobosin with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jin-Hua, Guo, Qing-Feng, Liu, Qiu-Ge, He, Bao-Xia, Song, Wen-Ping, Yin, Zhen-Hua, Li, Dong-Bei, Chen, Lin, Zhang, Wen-Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761161/
https://www.ncbi.nlm.nih.gov/pubmed/36544631
http://dx.doi.org/10.21037/atm-22-5320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761161/
https://www.ncbi.nlm.nih.gov/pubmed/36544631
http://dx.doi.org/10.21037/atm-22-5320

Ejemplares similares